个人简介

2003.09--2008.07，宜春学院，临床医学，学士

2008.09--2013.07，南方医科大学，肿瘤学，博士 

2012.01--2013.03，Fox Chase 肿瘤中心，分子生物学部，访问学者2013.08--2016.08，广东省人民医院，博士后

2016.08--2019.10，广东省人民医院，肺癌研究所，助理研究员

2019.10--今，广东省人民医院，肺癌研究所，副研究员

研究方向

肿瘤免疫治疗；肿瘤免疫细胞代谢重编程，细胞免疫治疗

代表性论著

1. Wang,Wen-jun#; Liu,Xiao-qing#; Wu,Si-pei#; Chen,Si-bei; Li,Yi-min; Nong,Ling-bo; Lie,Pu-yi; Huang,Li-yan; Cheng,Lin-ling; Lin,Yong-ping; He,Jian-xing*; Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics, Journal of Infectious Diseases, 2020, 1 November(2020:222): 1444-1451.

2. Wu, Si-Pei#; Liao, Ri-Qiang#; Tu, Hai-Yan; Wang, Wen-Jun; Dong, Zhong-Yi; Huang, Shu-Mei; Guo, Wei-Bang; Gou, Lan-Ying; Sun, Hui-Wen; Zhang, Qi; Xie, Zhi; Yan, Li-Xu; Su, Jian; Yang, JinJi; Zhong, Wen-Zhao; Zhang, Xu-Chao; Wu, Yi-Long*; Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Responseof Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy., Journal of Thoracic Oncology, 2018, 13(4).

3. Wang,Wen-jun; Wu,Si-pei; Liu,Jia-bin; Shi,Yong-sheng; Huang,Xue; Zhang,Qian-bing; Yao,Kai-tai*; MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells, Cancer Research, 2013, 72(3): 1219-1231.

4. Jinbo Tang#; Wu Sipei#; He Lin; Li Hongyang; Yang Qingqing; Yu Lin; Lie Puyi; Xiao Dakai; He Jianxing; Qiu Yuan; Wang Wenjun*; Prediction and Immune Infiltration Analysis of Lipid Metabolism-Related Immune Genes in the Treatment of Non-Small Cell Lung Cancer, Computers in Biology and Medicine, 2025.

5. Tian, Hongxia#; Li, Kezhen#; Chen, Jing; Guo, Weibang; Guo, Zepeng; Zhang, Shuilian; Xie, Zhi; Huang, Xin; Wu, Sipei*; Zhong, Wenzhao*; Impaired natural killer cell maturation in lung adenocarcinoma driven by FABP4 and SPON2 downregulation through disrupted lipid metabolism, Translational Lung Cancer Research, 2025, 14(5).

代表性课题

1. 国家自然科学基金面上项目，2019.01-2023.12，55万元，结题，主持

2. 国家自然科学基金面上项目，2022.01-2026.12，52万元，在研，主持

3. 广东省科技创新战略专项基金面上项目 2019.10 -2022.09, 10万元，结题，主持

4. 广州市科技计划项目，2019.04-2022.03, 20万元，结题，主持。

学术任职

1. 中国抗癌协会肿瘤标志专业委员会肿瘤多学科诊断（MDD）协作组，委员

2. 广东省抗癌协会肿瘤分子诊断专业委员会，委员。

执教课程（课程及教材建设）

1. 肿瘤学研究与进展

2. 基础医学前沿